Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial Activity

[Image: see text] We report a novel benzimidazole (BI) based DprE1 inhibitor that resulted from scaffold morphing of a 1,4-azaindole series. The clinical progression of the 1,4-azaindole series from our previous work validates the potential of exploring newer chemical entities with antimycobacterial...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS Med Chem Lett
Hauptverfasser: R, Manjunatha M., Shandil, Radha, Panda, Manoranjan, Sadler, Claire, Ambady, Anisha, Panduga, Vijender, Kumar, Naveen, Mahadevaswamy, Jyothi, Sreenivasaiah, M., Narayan, Ashwini, Guptha, Supreeth, Sharma, Sreevalli, Sambandamurthy, Vasan K., Ramachandran, Vasanthi, Mallya, Meenakshi, Cooper, Christopher, Mdluli, Khisi, Butler, Scott, Tommasi, Ruben, Iyer, Pravin S., Narayanan, Shridhar, Chatterji, Monalisa, Shirude, Pravin S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Chemical Society 2019
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6792157/
https://ncbi.nlm.nih.gov/pubmed/31620237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.9b00343
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge